Skip to main content
. 2016 Jun 8;6:131. doi: 10.3389/fonc.2016.00131

Table 2.

Patient-reported baseline clinical characteristics and pain.

Baseline (N = 31)
Discussed OIC with HCP during office visit (N, %) 
(N = 27 who had office visit) 24 (88.9)
Health rating (N, %)
 Excellent 0 (0.0)
 Very good 1 (3.2)
 Good 4 (12.9)
 Fair 13 (41.9)
 Poor 13 (41.9)
Type of chronic pain (N, %)a
 Pain related to cancer 30 (96.8)
 Back pain  15 (48.4)
 Joint pain 10 (32.3)
 Pain syndrome 10 (32.3)
 Neuralgia 3 (9.7)
 Fibromyalgia 2 (6.5)
 Rheumatoid arthritis 2 (6.5)
 Headache or migraine 1 (3.2)
 Otherb 2 (6.5)
Pain severity
 Average pain last 24 h (mean, SD) 5.2 (2.5)
 Average pain last 7 days (mean, SD) 5.2 (2.6)
How much does the constipation interfere with your ability of opioid medication to control pain? (N, %) N = 28
 No interference; pain adequately managed 5 (17.9)
 Little interference, pain mostly managed 11 (39.3)
 Moderate interference, pain moderately managed 11 (39.3)
 Complete interference with adequate pain management; pain not at all managed 1 (3.6)
In the past 7 days, did you change how you used your opioid pain medication(s), so that you could have BMs? (n, % yes) 3 (9.7)
 If yes: how change (N, %) N = 3
  No longer take my pain medication 0 (0.0)
  Reduced how much of my pain medication I use 2 (66.7)
  Temporarily interrupted the use of pain medication 0 (0.0)
  Switched to a different pain medication 0 (0.0)
  Other 1 (33.3)

aThis category is not mutually exclusive, and participants were able to report more than one type of chronic pain.

bOther includes liver metastases (N = 1) and leg/ankle cramp (N = 1).

BM, bowel movement; HCP, health-care provider; OIC, opioid-induced constipation.